Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

Effects of Trans-Auricular Vagal Stimulation on Neuromotor Recovery in Subacute Stroke During Technological and Traditional Training

NCT07254390 · Istituti Clinici Scientifici Maugeri SpA · Updated 12 May 2026

What is being tested
Active trans-auricular vagus nerve stimulation (tVNS); Sham tVNS; Khymeia robotic upper limb rehabilitation; Traditional Rehabilitation
For
Stroke
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 48 people. The full rules are on the registry page.
Where
Italy
When
Starts or started 8 Jan 2025, ends 3 April 2027. Registered 28 Nov 2025.
Results
None posted yet.

In the researchers' words

This randomized pilot clinical study aims to investigate the effects of trans-auricular vagus nerve stimulation (tVNS) on neuromotor recovery in patients in the subacute phase after stroke. Participants admitted for intensive rehabilitation at ICS Maugeri Centers (Montescano, Pavia, Nervi) will be randomized into four groups receiving either traditional or technological rehabilitation (Khymeia device), combined with active or sham tVNS. The Parasym® device (CE 0197) delivers non-invasive stimulation of the auricular branch of the vagus nerve at the left ear for 60 minutes daily. The primary outcome is the improvement in upper limb motor function, assessed by the Fugl-Meyer scale. Secondary outcomes include other clinical, cognitive, and psychological measures, as well as neurophysiological and cardiovascular autonomic parameters. The study hypothesizes that coupling tVNS with rehabilitation enhances cortical plasticity and accelerates motor recovery. Adverse effects are expected to be minimal, with previous studies reporting only mild transient skin irritation. The results may provide new insights into the neurophysiological mechanisms of recovery and support the integration of non-invasive neuromodulation in post-stroke rehabilitation.
ClinicalTrials.gov, NCT07254390

Sites

  • ICS Maugeri - MontescanoMontescano, Pavia, Italy